NM_212482.4(FN1):c.3221A>G (p.Glu1074Gly) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 4, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003819804.2

Allele description [Variation Report for NM_212482.4(FN1):c.3221A>G (p.Glu1074Gly)]

NM_212482.4(FN1):c.3221A>G (p.Glu1074Gly)

Gene:

FN1:fibronectin 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q35

Genomic location:

Preferred name:

NM_212482.4(FN1):c.3221A>G (p.Glu1074Gly)

HGVS:

NC_000002.12:g.215404421T>C
NG_012196.1:g.36648A>G
NG_012196.2:g.36647A>G
NM_001306129.2:c.3221A>G
NM_001306130.2:c.3221A>G
NM_001306131.2:c.3221A>G
NM_001306132.2:c.3221A>G
NM_001365517.2:c.3221A>G
NM_001365518.2:c.3221A>G
NM_001365519.2:c.3221A>G
NM_001365520.2:c.3221A>G
NM_001365521.2:c.3221A>G
NM_001365522.2:c.3221A>G
NM_001365523.2:c.3221A>G
NM_001365524.2:c.3221A>G
NM_002026.4:c.3221A>G
NM_212474.3:c.3221A>G
NM_212476.3:c.3221A>G
NM_212478.3:c.3221A>G
NM_212482.4:c.3221A>GMANE SELECT
NP_001293058.2:p.Glu1074Gly
NP_001293059.2:p.Glu1074Gly
NP_001293060.2:p.Glu1074Gly
NP_001293061.2:p.Glu1074Gly
NP_001352446.1:p.Glu1074Gly
NP_001352447.1:p.Glu1074Gly
NP_001352448.1:p.Glu1074Gly
NP_001352449.1:p.Glu1074Gly
NP_001352450.1:p.Glu1074Gly
NP_001352451.1:p.Glu1074Gly
NP_001352452.1:p.Glu1074Gly
NP_001352453.1:p.Glu1074Gly
NP_002017.2:p.Glu1074Gly
NP_997639.2:p.Glu1074Gly
NP_997641.2:p.Glu1074Gly
NP_997643.2:p.Glu1074Gly
NP_997647.2:p.Glu1074Gly
NC_000002.11:g.216269144T>C

Protein change:

E1074G

Molecular consequence:

NM_001306129.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001306130.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001306131.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001306132.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365517.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365518.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365519.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365520.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365521.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365522.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365523.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001365524.2:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_002026.4:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_212474.3:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_212476.3:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_212478.3:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_212482.4:c.3221A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Profile neighbors for GEO Profiles (Select 132577063) (99)
GEO Profiles
Profile neighbors for GEO Profiles (Select 132563019) (128)
GEO Profiles
MicroRNA-135b overexpression effect on prostate cancer cell line: time course
MicroRNA-135b overexpression effect on prostate cancer cell line: time course
Accession: GDS6100

GEO DataSets
Related DataSets for GEO Profiles (Select 132578063) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004619387	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jan 4, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004619387

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jan 4, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004619387.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 1074 of the FN1 protein (p.Glu1074Gly). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FN1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FN1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine